SynthesisEuropean journal of clinical pharmacology2020

Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence - a systematic review and meta-analysis.

Susanna M Wallerstedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.